The Prostate Health Index (PHI) is a diagnostic tool that combines total PSA, free PSA, and [-2]proPSA to improve the accuracy of prostate cancer detection and reduce unnecessary biopsies. It provides a more specific assessment of prostate cancer risk compared to PSA testing alone, aiding in better clinical decision-making.